Reduction of weight and left ventricular mass with serotonin uptake inhibition in obese patients with systemic hypertension.
Jordan
J
J
Department of Internal Medicine, Ochsner Clinic, New Orleans, Louisiana 70121, USA.
Messerli
F H
FH
Lavie
C J
CJ
Aepfelbacher
F C
FC
Soria
F
F
D015057:1-Naphthylamine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy* / Q000503:physiopathology; D009765:Obesity / Q000188:drug therapy* / Q000503:physiopathology; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage*; D020280:Sertraline; D016037:Single-Blind Method; D015431:Weight Loss / Q000187:drug effects*
D015057:1-Naphthylamine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline